Robert M Davis is Chairman, CEO & President of Merck & Co., Inc.. Currently has a direct ownership of 348,326 shares of MRK, which is worth approximately $39.6 Million. The most recent transaction as insider was on Feb 14, 2024, when has been sold 85,021 shares (Common Stock) at a price of $125.4 per share, resulting in proceeds of $10,661,633. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 348K
0% 3M change
28.15% 12M change
Total Value Held $39.6 Million

Robert M Davis Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 14 2024
SELL
Open market or private sale
$10,661,633 $125.4 p/Share
85,021 Reduced 19.62%
348,326 Common Stock
Feb 14 2024
BUY
Exercise of conversion of derivative security
$6,268,598 $73.73 p/Share
85,021 Added 16.4%
433,347 Common Stock
Feb 13 2024
SELL
Open market or private sale
$18,909,000 $126.06 p/Share
150,000 Reduced 30.1%
348,326 Common Stock
Feb 13 2024
BUY
Exercise of conversion of derivative security
$11,182,500 $74.55 p/Share
150,000 Added 23.14%
498,326 Common Stock
Jan 22 2024
BUY
Grant, award, or other acquisition
$9,137,589 $119.43 p/Share
76,510 Added 18.01%
348,326 Common Stock
Apr 28 2023
SELL
Open market or private sale
$16,472,801 $114.93 p/Share
143,329 Reduced 34.53%
271,816 Common Stock
Apr 28 2023
BUY
Exercise of conversion of derivative security
$8,032,157 $56.04 p/Share
143,329 Added 25.66%
415,145 Common Stock
Jan 23 2023
BUY
Grant, award, or other acquisition
$2,661,733 $109.88 p/Share
24,224 Added 8.18%
271,816 Common Stock
Nov 09 2022
SELL
Open market or private sale
$17,237,320 $102.84 p/Share
167,613 Reduced 40.37%
247,592 Common Stock
Nov 09 2022
BUY
Exercise of conversion of derivative security
-
167,613 Added 28.76%
415,205 Common Stock
Feb 24 2022
BUY
Grant, award, or other acquisition
$2,197,655 $73.51 p/Share
29,896 Added 10.77%
247,592 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
$3,387,070 $72.62 p/Share
46,641 Added 17.64%
217,696 Common Stock
Oct 05 2020
SELL
Open market or private sale
$20,360,651 $81.03 p/Share
251,273 Reduced 59.5%
171,055 Common Stock
Oct 05 2020
BUY
Exercise of conversion of derivative security
-
251,273 Added 37.3%
422,328 Common Stock
Feb 28 2020
BUY
Grant, award, or other acquisition
$2,556,798 $76.56 p/Share
33,396 Added 16.33%
171,055 Common Stock
Jun 25 2019
SELL
Open market or private sale
$18,566,231 $85.67 p/Share
216,718 Reduced 61.15%
137,659 Common Stock
Jun 25 2019
BUY
Exercise of conversion of derivative security
-
216,718 Added 37.95%
354,377 Common Stock
Mar 25 2019
SELL
Open market or private sale
$15,864,081 $82.38 p/Share
192,572 Reduced 58.31%
137,659 Common Stock
Mar 25 2019
BUY
Exercise of conversion of derivative security
$11,211,542 $58.22 p/Share
192,572 Added 36.83%
330,231 Common Stock
Feb 25 2019
BUY
Grant, award, or other acquisition
$2,460,432 $80.38 p/Share
30,610 Added 18.19%
137,659 Common Stock
Feb 27 2018
BUY
Grant, award, or other acquisition
$1,691,286 $54.72 p/Share
30,908 Added 22.55%
106,128 Common Stock
May 09 2017
SELL
Payment of exercise price or tax liability
$2,850,365 $64.01 p/Share
44,530 Reduced 37.73%
73,500 Common Stock
May 09 2017
BUY
Exercise of conversion of derivative security
-
85,881 Added 42.12%
118,030 Common Stock
Feb 27 2017
BUY
Grant, award, or other acquisition
$2,101,471 $65.85 p/Share
31,913 Added 50.0%
31,913 Common Stock

Also insider at

DUK
Duke Energy CORP Utilities
RMD

Robert M Davis

Chairman, CEO & President
Kenilworth, NJ

Track Institutional and Insider Activities on MRK

Follow Merck & Co., Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRK shares.

Notify only if

Insider Trading

Get notified when an Merck & Co., Inc. insider buys or sells MRK shares.

Notify only if

News

Receive news related to Merck & Co., Inc.

Track Activities on MRK